Page last updated: 2024-11-03

probenecid and Cross Infection

probenecid has been researched along with Cross Infection in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Cross Infection: Any infection which a patient contracts in a health-care institution.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PLATTNER, HC1
SCHERER, J1

Other Studies

1 other study available for probenecid and Cross Infection

ArticleYear
[PRESENT STATUS OF THE TREATMENT OF STAPHYLOCOCCAL DISEASES].
    Schweizerische medizinische Wochenschrift, 1965, Volume: 95

    Topics: Anti-Bacterial Agents; Cross Infection; Drug Therapy; Humans; Methicillin; Oxacillin; Penicillin G;

1965